Carregant...

Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain

BACKGROUND AND PURPOSE: Most of the pharmaceuticals target G-protein-coupled receptors (GPCRs) which can generally activate different signalling events. The aim of this study was to achieve functional selectivity of corticotropin-releasing factor receptor type 1 (CRF(1)) ligands. EXPERIMENTAL APPROA...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Beyermann, M, Heinrich, N, Fechner, K, Furkert, J, Zhang, W, Kraetke, O, Bienert, M, Berger, H
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2007
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2014118/
https://ncbi.nlm.nih.gov/pubmed/17533422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0707293
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!